Question 1

How does Barringtonia racemosa work to reduce fever?

Accepted Answer

Barringtonia racemosa contains bioactive compounds including saponins, lupeol, flavonoids, and phenolics that contribute to its antipyretic and anti-inflammatory properties. These compounds are believed to inhibit inflammatory mediators and reduce prostaglandin synthesis, which helps lower elevated body temperature during fever. The plant's traditional use for fever treatment spans Malay, Indian, and Pacific medicine systems. Evidence level C indicates support from limited clinical studies and substantial traditional use, though the exact molecular mechanisms require further investigation through controlled research.

Question 2

Is Barringtonia racemosa safe during pregnancy?

Accepted Answer

Barringtonia racemosa is considered unsafe during pregnancy and should be avoided entirely. The plant contains saponins that can cause toxicity and may potentially stimulate uterine contractions, posing risks to fetal development. Traditional medicine systems across Malaysia, India, and the Pacific Islands have historically contraindicated internal use in pregnant women. There is insufficient safety data for breastfeeding women as well. Women who are pregnant, planning pregnancy, or breastfeeding should not use this herb in any form without explicit guidance from a qualified healthcare provider.

Question 3

What is the recommended dosage for Barringtonia racemosa?

Accepted Answer

The traditional adult dosage for Barringtonia racemosa is 5-10 grams of bark or leaf prepared as a decoction, taken once or twice daily. To prepare, boil the plant material in water for 15-20 minutes, then strain before consumption. Users should not exceed this recommended range, as higher doses may cause saponin toxicity and gastrointestinal upset. Evidence level C indicates this dosing is based on traditional use rather than standardized clinical trials. Starting with lower doses and adjusting based on individual tolerance is advisable.

Question 4

Does Barringtonia racemosa interact with any medications?

Accepted Answer

There are no well-documented drug interactions for Barringtonia racemosa in current medical literature. However, due to its saponin content, theoretical interactions may exist with antipyretic medications, anti-inflammatory drugs, and agents affecting gastrointestinal function. Saponins can potentially enhance drug absorption or cause additive effects. Patients taking prescription medications should consult a qualified healthcare provider before using Barringtonia racemosa. Evidence level C applies to interaction data, meaning recommendations are based on theoretical concerns and traditional knowledge rather than formal interaction studies.

Question 5

What are the side effects of taking Barringtonia racemosa?

Accepted Answer

The primary side effects of Barringtonia racemosa are gastrointestinal in nature, including nausea, vomiting, and stomach upset, particularly when consumed in high doses. These effects are attributed to the saponin content, which can irritate the digestive tract lining. Internal use of high doses is specifically contraindicated due to potential saponin toxicity. Users should discontinue use if gastrointestinal symptoms develop and seek medical attention if symptoms persist. Evidence level C indicates side effect data comes from traditional use reports and limited clinical observation rather than systematic safety studies.

Barringtonia racemosa

Sources et citations

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Sécurité et effets indésirables

Grossesse et allaitement

Synthèse des preuves

Sources PubMed

Sources gouvernementales